Cargando…
Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients
BACKGROUND: Many studies offer excellent demonstration of the ability of bone morphogenic protein (BMP) to enhance fusion rates in anterior as well as posterior lumbar surgery. Recently, BMP has also been shown to increase arthrodesis rates in anterior cervical surgery, albeit with concomitant incre...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162798/ https://www.ncbi.nlm.nih.gov/pubmed/21886882 http://dx.doi.org/10.4103/2152-7806.83726 |
_version_ | 1782210872610914304 |
---|---|
author | Xu, Risheng Bydon, Mohamad Sciubba, Daniel M. Witham, Timothy F. Wolinsky, Jean-Paul Gokaslan, Ziya L. Bydon, Ali |
author_facet | Xu, Risheng Bydon, Mohamad Sciubba, Daniel M. Witham, Timothy F. Wolinsky, Jean-Paul Gokaslan, Ziya L. Bydon, Ali |
author_sort | Xu, Risheng |
collection | PubMed |
description | BACKGROUND: Many studies offer excellent demonstration of the ability of bone morphogenic protein (BMP) to enhance fusion rates in anterior as well as posterior lumbar surgery. Recently, BMP has also been shown to increase arthrodesis rates in anterior cervical surgery, albeit with concomitant increases in complication rates. To date, however, few studies have investigated the safety and efficacy of BMP in cervical surgeries approached posteriorly. METHODS: We retrospectively reviewed 204 consecutive patients with degenerative cervical spinal conditions necessitating posterior cervical fusion at a single institution over the past 4 years. The incidence of postoperative mechanical neck pain, fusion rates, as well as neurologic outcomes were compared between patients who received BMP vs those who did not receive BMP intraoperatively. RESULTS: There were no significant differences in preoperative variables between the non-BMP vs the BMP cohorts. Over an average follow-up of 24.2 months, there were no significant differences between the two cohorts in duration of hospitalization, cerebrospinal fluid leakage, deep vein thrombosis, pulmonary embolism, hyperostosis, infection, pneumonia, hematoma, C5 palsy, wound dehiscence, reoperation rates, or Nurick/ASIA scores. Eleven (7.1%) patients in the non-BMP group experienced instrumentation failure vs none in the BMP group (P=0.06). Patients receiving BMP had a significantly increased rate of fusion by the chi-square test (P=0.01) and the log-rank test (P=0.02). However, patients receiving BMP also had the highest rates of recurrent/persistent neck pain by the chi-square test (P=0.003) and the log-rank test (P=0.01). CONCLUSIONS: To date, few studies have evaluated the safety and efficacy of BMP in the posterior cervical spine. Here, we show that BMP usage does not increase complication rates, but it significantly increases arthrodesis rates and also may increase the rate of recurrent/persistent neck pain. |
format | Online Article Text |
id | pubmed-3162798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-31627982011-08-31 Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients Xu, Risheng Bydon, Mohamad Sciubba, Daniel M. Witham, Timothy F. Wolinsky, Jean-Paul Gokaslan, Ziya L. Bydon, Ali Surg Neurol Int Original Article BACKGROUND: Many studies offer excellent demonstration of the ability of bone morphogenic protein (BMP) to enhance fusion rates in anterior as well as posterior lumbar surgery. Recently, BMP has also been shown to increase arthrodesis rates in anterior cervical surgery, albeit with concomitant increases in complication rates. To date, however, few studies have investigated the safety and efficacy of BMP in cervical surgeries approached posteriorly. METHODS: We retrospectively reviewed 204 consecutive patients with degenerative cervical spinal conditions necessitating posterior cervical fusion at a single institution over the past 4 years. The incidence of postoperative mechanical neck pain, fusion rates, as well as neurologic outcomes were compared between patients who received BMP vs those who did not receive BMP intraoperatively. RESULTS: There were no significant differences in preoperative variables between the non-BMP vs the BMP cohorts. Over an average follow-up of 24.2 months, there were no significant differences between the two cohorts in duration of hospitalization, cerebrospinal fluid leakage, deep vein thrombosis, pulmonary embolism, hyperostosis, infection, pneumonia, hematoma, C5 palsy, wound dehiscence, reoperation rates, or Nurick/ASIA scores. Eleven (7.1%) patients in the non-BMP group experienced instrumentation failure vs none in the BMP group (P=0.06). Patients receiving BMP had a significantly increased rate of fusion by the chi-square test (P=0.01) and the log-rank test (P=0.02). However, patients receiving BMP also had the highest rates of recurrent/persistent neck pain by the chi-square test (P=0.003) and the log-rank test (P=0.01). CONCLUSIONS: To date, few studies have evaluated the safety and efficacy of BMP in the posterior cervical spine. Here, we show that BMP usage does not increase complication rates, but it significantly increases arthrodesis rates and also may increase the rate of recurrent/persistent neck pain. Medknow Publications Pvt Ltd 2011-08-13 /pmc/articles/PMC3162798/ /pubmed/21886882 http://dx.doi.org/10.4103/2152-7806.83726 Text en Copyright: © 2011 Xu R. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Original Article Xu, Risheng Bydon, Mohamad Sciubba, Daniel M. Witham, Timothy F. Wolinsky, Jean-Paul Gokaslan, Ziya L. Bydon, Ali Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients |
title | Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients |
title_full | Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients |
title_fullStr | Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients |
title_full_unstemmed | Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients |
title_short | Safety and efficacy of rhBMP2 in posterior cervical spinal fusion for subaxial degenerative spine disease: Analysis of outcomes in 204 patients |
title_sort | safety and efficacy of rhbmp2 in posterior cervical spinal fusion for subaxial degenerative spine disease: analysis of outcomes in 204 patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162798/ https://www.ncbi.nlm.nih.gov/pubmed/21886882 http://dx.doi.org/10.4103/2152-7806.83726 |
work_keys_str_mv | AT xurisheng safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients AT bydonmohamad safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients AT sciubbadanielm safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients AT withamtimothyf safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients AT wolinskyjeanpaul safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients AT gokaslanziyal safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients AT bydonali safetyandefficacyofrhbmp2inposteriorcervicalspinalfusionforsubaxialdegenerativespinediseaseanalysisofoutcomesin204patients |